Peer Exchange


Dravet Syndrome and Lennox-Gastaut Syndrome: Recent Treatment Advances

A discussion regarding the prevalence of and diagnostic process for Dravet syndrome.

Key opinion leaders discuss how to avoid misdiagnosing Lennox-Gastaut syndrome and enumerate the various types of associated seizures.

Expert neurologists consider the diagnostic tools available to accurately determine a patient’s status for Dravet and Lennox-Gastaut Syndrome.

The impact of Dravet and Lennox-Gastaut syndrome on patients and caregivers.

Transitioning patients from adolescent to adult care.

Key opinion leaders consider the challenges of administering medication and discuss how to circumvent nonadherence. 

Physicians consider the management of Dravet syndrome and discuss available treatments as well as their toxicity profiles.

Finding the best treatment plan, what medications to avoid, and developing a reliable rescue plan for Dravet syndrome.

A discussion regarding the approved and frontline therapies for Lennox-Gastaut syndrome.

When to decide between dietary therapy, vagus nerve stimulation, or corpus callosotomy for patients with Dravet and Lennox-Gastaut syndromes.

Key opinion leaders discuss the efficacy of medical cannabis to mitigate seizures associated with Dravet and Lennox-Gastaut syndromes, and emphasize the importance of recommending FDA-approved treatments to patients.

An overview of the clinical trials that led to the approval of cannabidiol oral solution for the treatment of Dravet and Lennox-Gastaut syndromes.

Expert neurologists consider the use of fenfluramine oral solution to treat Dravet and Lennox-Gastaut syndromes.

Key opinion leaders consider the future of treatment for Dravet and Lennox-Gastaut syndromes, and provide community neurologists with management advice.
SAP Partner Banner